Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Cencora
Cencora to invest $1bn in US pharma distribution network
Celltrion
Celltrion Signs Licensing Deal with U.S. Kaigene for Two Antibody Drug Candidates
Lunai Bioworks
Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
uniQure Staggers as FDA Questions Data for Huntington’s Gene Therapy Candidate
Agency torpedoes company's plans to submit BLA for gene therapy AMT-130 in Q1 2026.
Kimberly-Clark buys troubled Tylenol-maker Kenvue for $48.7bn
Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn.
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges
Femasys (FEMY) on Monday said that the FDA approved continuation of the final phase of its FemBloc pivotal trial, sending shares 25% higher in premarket trading.
Praxis announces
Praxis announces accelerated development path for relutrigine in SCN2A and SCN8A DEE patients following positive FDA feedback
Orum Therapeutics Announces Presentation of Preclinical Data for ORM-1153
Orum Therapeutics Announces Presentation of Preclinical Data for ORM-1153 at the 2025 American Society of Hematology (ASH) Annual Meeting
Myeloma
Myeloma treatment HDP-101 put on FDA fast track
Evotec Announces Progress
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
Tylenol (paracetamol)
Tylenol (paracetamol) fights autism claims, slams proposed FDA warning label as 'unsupported' by science
Cullinan Therapeutics showcases
Cullinan Therapeutics showcases preclinical data for autoimmune drug CLN-978
33
34
35
36
37
38
39
40
41
